OLAPLEX Reports Fourth Quarter and Fiscal Year 2024 Results: A Mixed Bag of Performance Metrics
Tuesday, Mar 4, 2025 6:55 am ET
7min read Olaplex Holdings, Inc. (NASDAQ: OLPX), the innovative, science-enabled, technology-driven beauty company, recently announced its financial results for the fourth quarter and fiscal year ended December 31, 2024. The company's performance metrics for the period provide a mixed bag of growth and decline, with both positive and negative trends across various channels and financial indicators.
Net Sales and channel Performance
OLAPLEX's net sales decreased by 9.8% to $100.7 million in the fourth quarter of 2024 compared to the same period in 2023. The company's fiscal year 2024 net sales also decreased by 7.8% to $422.7 million. The changes in net sales by channel have impacted the company's overall financial performance, with varying trends observed in each channel.
* Specialty Retail: This channel showed an increase of 5.7% to $28.8 million in the fourth quarter and 5.4% to $142.3 million for the fiscal year 2024 compared to the same periods in 2023. This positive trend contributed to the overall net sales, despite the decline in other channels.
* Professional: The professional channel saw a decrease of 27.1% to $31.0 million in the fourth quarter and 19.3% to $145.3 million for the fiscal year 2024. This significant drop negatively impacted the overall net sales and may indicate a decline in demand or market share in the professional hair care industry.
* Direct-To-Consumer: This channel experienced a decrease of 2.5% to $40.9 million in the fourth quarter and 5.7% to $135.0 million for the fiscal year 2024. The decline in direct-to-consumer sales may suggest a shift in consumer behavior or increased competition in the e-commerce space.
in fiscal 2024's revenue by business(3111)fiscal 2023's total revenue yoy increase rate(6519)fiscal 2023's rsi(rsi24 value)(5437)fiscal 2023's total revenue yoy increase rate;fiscal 2023's rsi(rsi24 value)(5437)in q4 2024's revenue by region(1535)q4 2023's accounts payable(6519)
Revenue By Business2024.12.31  | Total Revenue YoY%2023.03.31 | Total Revenue YoY%2023.06.30 | Total Revenue YoY%2023.09.30 | Total Revenue YoY%2023.12.31  | RSI(RSI24 Value)2023.12.29 | Revenue By Region2024.12.31 | Accounts Payable(USD)2023.12.31 |
|---|---|---|---|---|---|---|---|
| 224.00K | -- | 263.36 | 104.38 | 49.83K | 53.11 | 224.00K | 5.58M |
| 2.33B | -19.17 | -21.54 | -25.73 | 3.91K | 65.82 | 28.00M | -- |
| 259.82M | -16.63 | -13.53 | -25.54 | 2.13K | 56.40 | 193.09M | 134.98M |
| 55.52M | 25.10 | -18.29 | -25.94 | 1.56K | 60.59 | 43.85M | 25.60M |
| 424.78K | -- | 252.27 | 198.57 | 621.17 | 45.21 | 470.56K | 1.20M |
| 2.43M | 16.68 | 295.87 | 327.63 | 598.62 | 59.88 | 449.00K | 81.65M |
| 23.07M | -- | -99.18 | 2K | 575.30 | 51.95 | 1.26M | 21.25M |
| 70.00K | -89.96 | 473.80 | -79.76 | 523.51 | 44.20 | 70.00K | 12.86M |
| 122.34M | 382.13 | 702.51 | 239.87 | 521.89 | 73.33 | 7.09M | -- |
| 67.00M | -5.23 | 3.14 | -27.99 | 487.22 | 60.47 | 3.44B | 881.00M |
Ticker |
|---|
| UECUranium Energy |
| ALITAlight |
| PENGPenguin Solutions |
| PARPAR Technology |
| INBSIntelligent Bio |
| FPHFive Point Holdings |
| ENVXEnovix |
| IEIvanhoe Electric |
| ASNDAscendis Pharma |
| BAXBaxter International |
View 1388 results
Gross Profit Margin and Adjusted EBITDA Margin
OLAPLEX's gross profit margin decreased to 66.3% in the fourth quarter and 69.2% for the fiscal year 2024, compared to 68.7% and 69.5% in the same periods in 2023, respectively. This decrease in gross profit margin further eroded the company's profitability. Additionally, the adjusted EBITDA margin decreased to 17.4% in the fourth quarter and 30.7% for the fiscal year 2024, compared to 32.2% and 38.0% in the same periods in 2023, respectively.
Investment in Research and Development, Marketing, and Talent
OLAPLEX's investment in research and development, marketing, and talent has contributed to its financial performance in 2024, although the overall net sales and earnings have decreased compared to 2023. The company's focus on innovation, brand building, and attracting top talent has likely contributed to the development of new products and technologies that drive sales and maintain the company's competitive edge in the bond-building hair care space.
For fiscal year 2025, OLAPLEX expects that continued investment in research and development, marketing, and talent will have a positive impact on its financial performance. The company's guidance for fiscal year 2025 includes:
* Net sales of $410 million to $431 million, which represents a potential increase of 1.6% to 4.4% compared to the actual net sales of $423 million in 2024.
* Adjusted gross profit margin of 70.5% to 71.5%, which is in line with the adjusted gross profit margin of 71.4% in 2024.
* Adjusted EBITDA margin of 20% to 22%, which represents a potential increase of 6.7% to 9.4% compared to the adjusted EBITDA margin of 30.7% in 2024.
These expected improvements in financial performance suggest that OLAPLEX's continued investment in research and development, marketing, and talent will drive growth and enhance the company's competitive position in the hair care industry.
In conclusion, OLAPLEX's financial performance in 2024 has been a mixed bag, with both positive and negative trends across various channels and financial indicators. The company's investment in research and development, marketing, and talent has contributed to its financial performance, and the company expects continued investment in these areas to drive growth in fiscal year 2025. As OLAPLEX continues to navigate the competitive hair care market, investors should monitor the company's performance and strategic initiatives to assess its long-term prospects.
_602209e51748961823933.jpeg)
